SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-422658
Filing Date
2014-11-24
Accepted
2014-11-24 09:05:37
Documents
4
Period of Report
2014-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d826184d8k.htm 8-K 23829
2 EX-99.1 d826184dex991.htm EX-99.1 15316
3 GRAPHIC g826184g39d16.jpg GRAPHIC 2476
4 GRAPHIC g826184g53y11.jpg GRAPHIC 24192
  Complete submission text file 0001193125-14-422658.txt   77299
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 141245017
SIC: 2834 Pharmaceutical Preparations